Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Julia Hackenberg has worked on the following 4 EPO patent applications which have been published in the last five years:

EP15729755

NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT

IPC classification:
A61K 38/16, A61P 19/00, A61P 21/00
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Julia Hackenberg, Merz Pharma GmbH & Co. KGaA
Status:
EXAMINATION REQUESTED
EP15730689

USE OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS FOR THE TREATMENT OF PATIENTS HAVING CERTAIN MUSCLE-RELATED DISORDERS

IPC classification:
A61K 38/48, A61P 21/02
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Julia Hackenberg, Merz Pharma GmbH & Co. KGaA
Status:
EXAMINATION REQUESTED
EP15731248

NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT

IPC classification:
A61K 38/16, A61P 21/00
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Julia Hackenberg, Merz Pharma GmbH & Co. KGaA
Status:
EXAMINATION REQUESTED
EP15730959

NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT

IPC classification:
A61K 38/48, A61P 21/00
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Julia Hackenberg, Merz Pharma GmbH & Co. KGaA
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature